Atai Beckley, Inc. (ATAI)
7.345
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
7.345
0.00 (0.00%)
After-Hours: 16:51
Atai Beckley Research and Development Expense (TTM) : 79.04M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 79.04M |
| March 31, 2026 | 62.05M |
| December 31, 2025 | 55.51M |
| September 30, 2025 | 48.84M |
| June 30, 2025 | 46.78M |
| March 31, 2025 | 47.13M |
| September 30, 2024 | 50.32M |
| June 30, 2024 | 51.24M |
| March 31, 2024 | 54.12M |
| Date | Value |
|---|---|
| December 31, 2023 | 61.88M |
| September 30, 2023 | 69.65M |
| June 30, 2023 | 75.43M |
| March 31, 2023 | 77.96M |
| December 31, 2022 | 74.14M |
| September 30, 2022 | 65.28M |
| June 30, 2022 | 59.65M |
| March 31, 2022 | 65.70M |
| December 31, 2021 | 56.86M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 14.60B |
| GH Research Plc | 46.71M |
| Johnson & Johnson | 15.06B |
| Merck & Co., Inc. | 27.26B |
| Zoetis, Inc. | 722.00M |